Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Hematologic Neoplasms × nilotinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Neoplastic Processes 1 Myeloproliferative Disorders 1 Leukemia 1 Hematologic Diseases 1 Bronchiolitis Obliterans Syndrome 1 Bone Marrow Diseases 1

Interventions

talquetamab 2 ulixertinib 1 trastuzumab biosimilar HLX02 1 trametinib 1 sapanisertib 1 relatlimab 1 pertuzumab 1 palbociclib 1 osimertinib 1 omipalisib 1 larotrectinib 1 ivosidenib 1 ipatasertib 1 fedratinib 1 erdafitinib 1 enasidenib 1 defactinib 1 dabrafenib 1 copanlisib 1 capivasertib 1 binimetinib 1 adavosertib 1 X-Rays 1 Trastuzumab 1 Sunitinib 1 Specimen Handling 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Nuclear Medicine Department, Hospital 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡